GlucoLight, first hypoglycemic clamping study of its continuous, non-invasive glucose monitor, Sentris-100

August 22, 2007 - GlucoLight Corporation, company focused on blood glucose monitoring in the acute care environment, announced the successful conclusion of the company’s first hypoglycemic “clamping” study to evaluate its continuous, non-invasive glucose monitor, Sentris-100™. - GlucoLight's Press Room (PDF) -